TY - JOUR
T1 - Healthcare costs and outcomes associated with surgical site infections after coronary artery bypass grafting surgeries in Oman
AU - AlRiyami, Fatma M.
AU - Al-Rawajfah, Omar M.
AU - Al Sabei, Sulaiman
AU - Al Sabti, Hilal A.
AU - Khalaf, Atika
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - BACKGROUND: Surgical site infection (SSI) after coronary artery bypass graft (CABG) surgeries is considered a key indicator of the quality of healthcare services.OBJECTIVE: This study aimed to estimate the healthcare outcomes associated with SSIs after CABG surgeries in Oman in terms of mortality rate, case-fatality rate, LOS, readmission rate and healthcare costs.METHODS: The nested case-control study design was used based on retrospective data, which was conducted from 2016 to 2017. The case group encompassed all CABG patients with confirmed SSIs within 30 days of the surgery (
n = 104) while controls were CABG patients without SSIs (
n = 404).
RESULTS: Forty-four (42.3%) of the SSI patients were readmitted to the hospital compared to eight (2%) of the control group (
p < .001). Patients in the case group had a longer LOS (
M = 24.4,
SD = 44.6 days) compared to those in the control group (
M = 11,
SD = 21 days,
p = .003). The mean healthcare costs of cases (
M = Omani Rial [OMR] 3823,
SD = OMR 2516) were significantly greater than controls (
M = OMR 3154,
SD = OMR 1415,
p = .010).
CONCLUSION: Results from this study can be baseline data for formulating new hypotheses and testing the causal relationship between SSIs after CABG surgeries and the readmission rate, LOS and health care costs.Key messagesSurgical Site Infections (SSIs) are still a major complication after cardiac surgeries in Oman.SSIs after cardiac surgeries are associated with substantially increased healthcare costs and length of stay.SSIs after cardiac surgeries are associated with negative outcomes such as mortality and case-fatality rates.
AB - BACKGROUND: Surgical site infection (SSI) after coronary artery bypass graft (CABG) surgeries is considered a key indicator of the quality of healthcare services.OBJECTIVE: This study aimed to estimate the healthcare outcomes associated with SSIs after CABG surgeries in Oman in terms of mortality rate, case-fatality rate, LOS, readmission rate and healthcare costs.METHODS: The nested case-control study design was used based on retrospective data, which was conducted from 2016 to 2017. The case group encompassed all CABG patients with confirmed SSIs within 30 days of the surgery (
n = 104) while controls were CABG patients without SSIs (
n = 404).
RESULTS: Forty-four (42.3%) of the SSI patients were readmitted to the hospital compared to eight (2%) of the control group (
p < .001). Patients in the case group had a longer LOS (
M = 24.4,
SD = 44.6 days) compared to those in the control group (
M = 11,
SD = 21 days,
p = .003). The mean healthcare costs of cases (
M = Omani Rial [OMR] 3823,
SD = OMR 2516) were significantly greater than controls (
M = OMR 3154,
SD = OMR 1415,
p = .010).
CONCLUSION: Results from this study can be baseline data for formulating new hypotheses and testing the causal relationship between SSIs after CABG surgeries and the readmission rate, LOS and health care costs.Key messagesSurgical Site Infections (SSIs) are still a major complication after cardiac surgeries in Oman.SSIs after cardiac surgeries are associated with substantially increased healthcare costs and length of stay.SSIs after cardiac surgeries are associated with negative outcomes such as mortality and case-fatality rates.
KW - coronary bypass graft surgeries
KW - healthcare costs
KW - healthcare outcomes
KW - Surgical site infection
KW - Health Care Costs
KW - Humans
KW - Coronary Artery Bypass
KW - Retrospective Studies
KW - Surgical Wound Infection
KW - Case-Control Studies
KW - Oman
UR - http://www.scopus.com/inward/record.url?scp=85149372369&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149372369&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/59d59e63-8125-3af9-9968-a454f179e9cd/
U2 - 10.1080/07853890.2023.2184486
DO - 10.1080/07853890.2023.2184486
M3 - Article
C2 - 36856585
AN - SCOPUS:85149372369
SN - 0785-3890
VL - 55
SP - 793
EP - 799
JO - Annals of Medicine
JF - Annals of Medicine
IS - 1
ER -